Thanks for your interest in the ARRISA-UK study.
Randomisation of practices for this study is now closed and we are no longer accepting expressions of interest or GP Surveys.
To learn more about the study please see the About and Research Participation pages of this website.
Control and Intervention practices are reminded that special web pages with information for their practice are available via links which have been emailed to you. Alternatively, contact the study office if you have any questions.
The ARRISA-UK study is funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme (project number 13.34.70).The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK
A randomised controlled trial of GP practice staff training and high risk patient identification and flagging to reduce the occurrence of severe asthma related events.
It is funded by the NHS' National Institute for Health Research's Health Technology Assessment Programme.
Online training and follow up for one year for GPs Nurses and reception staff in managing care for those asthma patients identified as being at the highest risk of having a severe event.
Study Update - May 2022 - Research nearing completion
ARRISA-UK Study Update - May 2022 - Research nearing completion
The study has randomised all of the needed GP Practices; and no longer needs to recruit more practices.
The ARRISA observation period for all practices has ended, but this isn’t the end of the study! We had a lot of data to collect. Here’s a brief summary of what’s been happening for ARRISA over the last few months…
- NHS Digital have granted permission to access secondary care data in England and link the two datasets – a huge milestone for the study.
- Our funder (NIHR) has funded an extension to cover the costs and time to link primary and secondary care data, with a new study end date of 31/10/2022.
As COVID lockdown eased, our focus once again returned to completing the study as quickly as possible. Our sponsor and CRN agreed that we should be able to proceed as no patient facing work was required. We needed to contact practices to agree an updated data processing agreement and last steps.
We want to give a big thank you! 244 GP practices, over 90% of those participating, have completed primary care data extraction with our partners OPC; The secondary care data requests to NHS Digital in England, PHS in Scotland and NWIS in Wales are also proceeding.
We have begun work on the data analysis required for the analysis of the study and will disseminate that as soon as possible, likely in Early 2023.
This work is supported by the Asthma UK ,Centre for Applied Research [AUK-AC-2012-01]
Trial administered at the Norwich Clinical Trial Unit Norwich Medical School, University of East Anglia.